Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Neuroendocrinology. 2012 Aug 28;97(2):160–175. doi: 10.1159/000338669

Fig.2.

Fig.2

EB (A), PPT (A), STX (B) and G-1 (C), but not DPN (A), decrease daily food intake. Bars represent means and lines 1 S.E.M. of the daily intake elicited in animals treated with either EB (10 μg; s.c.), PPT (200 μg; s.c.), STX (3 mg; s.c.), G-1 (400 μg; s.c.), DPN (500 μg; s.c.) or their respective sesame oil (A), propylene glycol (B) or DMSO (C) vehicles (0.1 ml). *, Values that are significantly different (one-way ANOVA/LSD: P<.05 (A); Student’s t-test: P<.05 (B and C)) than those from vehicle-treated controls (n=4-7).